Skip to main content
. 2015 Oct 6;34:111. doi: 10.1186/s13046-015-0221-y

Fig. 3.

Fig. 3

Iatrogenic activation of CSCs with altered metabolic reprogramming. Non-CSCs are susceptible to chemotherapy and undergo apoptosis. Released PGE2 awakens the dormant CSCs localized in the niche. Proliferating CSCs are likely to exhibit additional metabolic reprogramming, concomitant with up-regulation of OXPHOS-related molecules